A controversial anti-malaria drug is being trialed as a therapy for COVID-19 at the B.C. seniors’ care home at the epicentre of the province’s novel coronavirus outbreak. Global News has confirmed that residents of the Lynn Valley Care Centre are receiving hydroxychloroquine as a part of an international study on the effectiveness of the drug. Forty-six residents and 24 staff at the facility have have tested positive for COVID-19.